H.R. 2340

119th Congress

In Committee

Advancing Enrollment and Reducing Drug Costs Act

Sponsored byDemocrat:Rep. Pappas, Chris [D-NH-1]NH· Introduced 25 mars 2025

1

Cosponsors

4

Actions

0

Amendments

0

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

25 mars 2025·1 year ago

Summary

Introduced in House · Updated 18 avril 2025

Advancing Enrollment and Reducing Drug Costs Act

This bill specifies that certain Medicaid enrollees automatically qualify for low-income subsidies under the Medicare prescription drug benefit. Specifically, the bill automatically qualifies individuals who were enrolled in Medicaid before they turned 65 (as part of Medicaid expansion under the Patient Protection and Affordable Care Act) and whose income is below 200% of the federal poverty line.

Timeline

4 actions

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    25 mars 2025 · IntroReferral

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    25 mars 2025 · IntroReferral

  3. Introduced in House

    25 mars 2025 · IntroReferral

  4. Introduced in House

    25 mars 2025 · IntroReferral

Sponsorship

1 cosponsors

Sponsor

Democrat:Rep. Pappas, Chris [D-NH-1]NH

Cosponsors

  • Democrat1100%

Classification

Policy area

Health
Pelosi Tracker
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.